Overview

Pharmacokinetics/Pharmacodynamics (PK/PD) of Cangrelor

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to: - Evaluate the tolerability of two cangrelor regimens. - Compare the PD of cangrelor regimens with oral clopidogrel.
Phase:
Phase 1
Details
Lead Sponsor:
The Medicines Company
Treatments:
Cangrelor